The global Immunosuppressant Drugs market is projected to grow from US$ 23730 million in 2023 to US$ 46360 million by 2029, at a Compound Annual Growth Rate (CAGR) of 11.8% during the forecast period.

Immunosuppressant Drugs Market

The US & Canada market for Immunosuppressant Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Immunosuppressant Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Immunosuppressant Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Immunosuppressant Drugs include Novartis, Astellas Pharma, Roche, Pfizer, Sanofi, Allergan, Bristol-Myers Squibb, AbbVie and Veloxis Pharmaceuticals, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Immunosuppressant Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Immunosuppressant Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Immunosuppressant Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunosuppressant Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Immunosuppressant Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Immunosuppressant Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Novartis, Astellas Pharma, Roche, Pfizer, Sanofi, Allergan, Bristol-Myers Squibb, AbbVie and Veloxis Pharmaceuticals, etc.

Scope of Immunosuppressant Drugs Market Report

Report Metric	Details
Report Name	Immunosuppressant Drugs Market
Accounted market size in 2023	US$ 23730 million
Forecasted market size in 2029	US$ 46360 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Calcineurin Inhibitors MTOR Inhibitors Anti-proliferative Agents Steroids Antibodies
Segment by Application	Kidney Bone Marrow Others
Segment by Region	US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Middle East, Africa, Latin America Brazil Mexico Turkey Israel GCC Countries
By Company	Novartis, Astellas Pharma, Roche, Pfizer, Sanofi, Allergan, Bristol-Myers Squibb, AbbVie, Veloxis Pharmaceuticals, GSK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Immunosuppressant Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Immunosuppressant Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunosuppressant Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

1 Study Coverage

1.1 Immunosuppressant Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Immunosuppressant Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Calcineurin Inhibitors

1.2.3 MTOR Inhibitors

1.2.4 Anti-proliferative Agents

1.2.5 Steroids

1.2.6 Antibodies

1.3 Market by Application

1.3.1 Global Immunosuppressant Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Kidney

1.3.3 Bone Marrow

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Immunosuppressant Drugs Sales Estimates and Forecasts 2018-2029

2.2 Global Immunosuppressant Drugs Revenue by Region

2.2.1 Global Immunosuppressant Drugs Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Immunosuppressant Drugs Revenue by Region (2018-2023)

2.2.3 Global Immunosuppressant Drugs Revenue by Region (2024-2029)

2.2.4 Global Immunosuppressant Drugs Revenue Market Share by Region (2018-2029)

2.3 Global Immunosuppressant Drugs Sales Estimates and Forecasts 2018-2029

2.4 Global Immunosuppressant Drugs Sales by Region

2.4.1 Global Immunosuppressant Drugs Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Immunosuppressant Drugs Sales by Region (2018-2023)

2.4.3 Global Immunosuppressant Drugs Sales by Region (2024-2029)

2.4.4 Global Immunosuppressant Drugs Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Immunosuppressant Drugs Sales by Manufacturers

3.1.1 Global Immunosuppressant Drugs Sales by Manufacturers (2018-2023)

3.1.2 Global Immunosuppressant Drugs Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunosuppressant Drugs in 2022

3.2 Global Immunosuppressant Drugs Revenue by Manufacturers

3.2.1 Global Immunosuppressant Drugs Revenue by Manufacturers (2018-2023)

3.2.2 Global Immunosuppressant Drugs Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Immunosuppressant Drugs Revenue in 2022

3.3 Global Key Players of Immunosuppressant Drugs, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Immunosuppressant Drugs Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Immunosuppressant Drugs, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Immunosuppressant Drugs, Product Offered and Application

3.8 Global Key Manufacturers of Immunosuppressant Drugs, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Immunosuppressant Drugs Sales by Type

4.1.1 Global Immunosuppressant Drugs Historical Sales by Type (2018-2023)

4.1.2 Global Immunosuppressant Drugs Forecasted Sales by Type (2024-2029)

4.1.3 Global Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

4.2 Global Immunosuppressant Drugs Revenue by Type

4.2.1 Global Immunosuppressant Drugs Historical Revenue by Type (2018-2023)

4.2.2 Global Immunosuppressant Drugs Forecasted Revenue by Type (2024-2029)

4.2.3 Global Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Immunosuppressant Drugs Price by Type

4.3.1 Global Immunosuppressant Drugs Price by Type (2018-2023)

4.3.2 Global Immunosuppressant Drugs Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Immunosuppressant Drugs Sales by Application

5.1.1 Global Immunosuppressant Drugs Historical Sales by Application (2018-2023)

5.1.2 Global Immunosuppressant Drugs Forecasted Sales by Application (2024-2029)

5.1.3 Global Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

5.2 Global Immunosuppressant Drugs Revenue by Application

5.2.1 Global Immunosuppressant Drugs Historical Revenue by Application (2018-2023)

5.2.2 Global Immunosuppressant Drugs Forecasted Revenue by Application (2024-2029)

5.2.3 Global Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Immunosuppressant Drugs Price by Application

5.3.1 Global Immunosuppressant Drugs Price by Application (2018-2023)

5.3.2 Global Immunosuppressant Drugs Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Immunosuppressant Drugs Market Size by Type

6.1.1 US & Canada Immunosuppressant Drugs Sales by Type (2018-2029)

6.1.2 US & Canada Immunosuppressant Drugs Revenue by Type (2018-2029)

6.2 US & Canada Immunosuppressant Drugs Market Size by Application

6.2.1 US & Canada Immunosuppressant Drugs Sales by Application (2018-2029)

6.2.2 US & Canada Immunosuppressant Drugs Revenue by Application (2018-2029)

6.3 US & Canada Immunosuppressant Drugs Market Size by Country

6.3.1 US & Canada Immunosuppressant Drugs Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Immunosuppressant Drugs Sales by Country (2018-2029)

6.3.3 US & Canada Immunosuppressant Drugs Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Immunosuppressant Drugs Market Size by Type

7.1.1 Europe Immunosuppressant Drugs Sales by Type (2018-2029)

7.1.2 Europe Immunosuppressant Drugs Revenue by Type (2018-2029)

7.2 Europe Immunosuppressant Drugs Market Size by Application

7.2.1 Europe Immunosuppressant Drugs Sales by Application (2018-2029)

7.2.2 Europe Immunosuppressant Drugs Revenue by Application (2018-2029)

7.3 Europe Immunosuppressant Drugs Market Size by Country

7.3.1 Europe Immunosuppressant Drugs Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Immunosuppressant Drugs Sales by Country (2018-2029)

7.3.3 Europe Immunosuppressant Drugs Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Immunosuppressant Drugs Market Size

8.1.1 China Immunosuppressant Drugs Sales (2018-2029)

8.1.2 China Immunosuppressant Drugs Revenue (2018-2029)

8.2 China Immunosuppressant Drugs Market Size by Application

8.2.1 China Immunosuppressant Drugs Sales by Application (2018-2029)

8.2.2 China Immunosuppressant Drugs Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Immunosuppressant Drugs Market Size by Type

9.1.1 Asia Immunosuppressant Drugs Sales by Type (2018-2029)

9.1.2 Asia Immunosuppressant Drugs Revenue by Type (2018-2029)

9.2 Asia Immunosuppressant Drugs Market Size by Application

9.2.1 Asia Immunosuppressant Drugs Sales by Application (2018-2029)

9.2.2 Asia Immunosuppressant Drugs Revenue by Application (2018-2029)

9.3 Asia Immunosuppressant Drugs Sales by Region

9.3.1 Asia Immunosuppressant Drugs Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Immunosuppressant Drugs Revenue by Region (2018-2029)

9.3.3 Asia Immunosuppressant Drugs Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Immunosuppressant Drugs Market Size by Type

10.1.1 Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Immunosuppressant Drugs Market Size by Application

10.2.1 Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Country

10.3.1 Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Novartis

11.1.1 Novartis Company Information

11.1.2 Novartis Overview

11.1.3 Novartis Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Novartis Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis Recent Developments

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Information

11.2.2 Astellas Pharma Overview

11.2.3 Astellas Pharma Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Astellas Pharma Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Astellas Pharma Recent Developments

11.3 Roche

11.3.1 Roche Company Information

11.3.2 Roche Overview

11.3.3 Roche Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Roche Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Roche Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Overview

11.4.3 Pfizer Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Pfizer Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Pfizer Recent Developments

11.5 Sanofi

11.5.1 Sanofi Company Information

11.5.2 Sanofi Overview

11.5.3 Sanofi Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Sanofi Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Sanofi Recent Developments

11.6 Allergan

11.6.1 Allergan Company Information

11.6.2 Allergan Overview

11.6.3 Allergan Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Allergan Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Allergan Recent Developments

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Information

11.7.2 Bristol-Myers Squibb Overview

11.7.3 Bristol-Myers Squibb Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Bristol-Myers Squibb Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Bristol-Myers Squibb Recent Developments

11.8 AbbVie

11.8.1 AbbVie Company Information

11.8.2 AbbVie Overview

11.8.3 AbbVie Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 AbbVie Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 AbbVie Recent Developments

11.9 Veloxis Pharmaceuticals

11.9.1 Veloxis Pharmaceuticals Company Information

11.9.2 Veloxis Pharmaceuticals Overview

11.9.3 Veloxis Pharmaceuticals Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.9.4 Veloxis Pharmaceuticals Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Veloxis Pharmaceuticals Recent Developments

11.10 GSK

11.10.1 GSK Company Information

11.10.2 GSK Overview

11.10.3 GSK Immunosuppressant Drugs Sales, Price, Revenue and Gross Margin (2018-2023)

11.10.4 GSK Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 GSK Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Immunosuppressant Drugs Industry Chain Analysis

12.2 Immunosuppressant Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Immunosuppressant Drugs Production Mode & Process

12.4 Immunosuppressant Drugs Sales and Marketing

12.4.1 Immunosuppressant Drugs Sales Channels

12.4.2 Immunosuppressant Drugs Distributors

12.5 Immunosuppressant Drugs Customers

13 Market Dynamics

13.1 Immunosuppressant Drugs Industry Trends

13.2 Immunosuppressant Drugs Market Drivers

13.3 Immunosuppressant Drugs Market Challenges

13.4 Immunosuppressant Drugs Market Restraints

14 Key Findings in The Global Immunosuppressant Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Veloxis Pharmaceuticals

GSK

List of Tables

Table 1. Global Immunosuppressant Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Calcineurin Inhibitors

Table 3. Major Manufacturers of MTOR Inhibitors

Table 4. Major Manufacturers of Anti-proliferative Agents

Table 5. Major Manufacturers of Steroids

Table 6. Major Manufacturers of Antibodies

Table 7. Global Immunosuppressant Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Immunosuppressant Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. Global Immunosuppressant Drugs Revenue by Region (2018-2023) & (US$ Million)

Table 10. Global Immunosuppressant Drugs Revenue by Region (2024-2029) & (US$ Million)

Table 11. Global Immunosuppressant Drugs Revenue Market Share by Region (2018-2023)

Table 12. Global Immunosuppressant Drugs Revenue Market Share by Region (2024-2029)

Table 13. Global Immunosuppressant Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 14. Global Immunosuppressant Drugs Sales by Region (2018-2023) & (K MT)

Table 15. Global Immunosuppressant Drugs Sales by Region (2024-2029) & (K MT)

Table 16. Global Immunosuppressant Drugs Sales Market Share by Region (2018-2023)

Table 17. Global Immunosuppressant Drugs Sales Market Share by Region (2024-2029)

Table 18. Global Immunosuppressant Drugs Sales by Manufacturers (2018-2023) & (K MT)

Table 19. Global Immunosuppressant Drugs Sales Share by Manufacturers (2018-2023)

Table 20. Global Immunosuppressant Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 21. Global Immunosuppressant Drugs Revenue Share by Manufacturers (2018-2023)

Table 22. Global Key Players of Immunosuppressant Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 23. Immunosuppressant Drugs Price by Manufacturers 2018-2023 (USD/MT)

Table 24. Global Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Immunosuppressant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunosuppressant Drugs as of 2022)

Table 26. Global Key Manufacturers of Immunosuppressant Drugs, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Immunosuppressant Drugs, Product Offered and Application

Table 28. Global Key Manufacturers of Immunosuppressant Drugs, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 31. Global Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 32. Global Immunosuppressant Drugs Sales Share by Type (2018-2023)

Table 33. Global Immunosuppressant Drugs Sales Share by Type (2024-2029)

Table 34. Global Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 35. Global Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 36. Global Immunosuppressant Drugs Revenue Share by Type (2018-2023)

Table 37. Global Immunosuppressant Drugs Revenue Share by Type (2024-2029)

Table 38. Immunosuppressant Drugs Price by Type (2018-2023) & (USD/MT)

Table 39. Global Immunosuppressant Drugs Price Forecast by Type (2024-2029) & (USD/MT)

Table 40. Global Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 41. Global Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 42. Global Immunosuppressant Drugs Sales Share by Application (2018-2023)

Table 43. Global Immunosuppressant Drugs Sales Share by Application (2024-2029)

Table 44. Global Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 45. Global Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 46. Global Immunosuppressant Drugs Revenue Share by Application (2018-2023)

Table 47. Global Immunosuppressant Drugs Revenue Share by Application (2024-2029)

Table 48. Immunosuppressant Drugs Price by Application (2018-2023) & (USD/MT)

Table 49. Global Immunosuppressant Drugs Price Forecast by Application (2024-2029) & (USD/MT)

Table 50. US & Canada Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 51. US & Canada Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 52. US & Canada Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 53. US & Canada Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 54. US & Canada Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 55. US & Canada Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 56. US & Canada Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 57. US & Canada Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 58. US & Canada Immunosuppressant Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 59. US & Canada Immunosuppressant Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 60. US & Canada Immunosuppressant Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 61. US & Canada Immunosuppressant Drugs Sales by Country (2018-2023) & (K MT)

Table 62. US & Canada Immunosuppressant Drugs Sales by Country (2024-2029) & (K MT)

Table 63. Europe Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 64. Europe Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 65. Europe Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 66. Europe Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 67. Europe Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 68. Europe Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 69. Europe Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 70. Europe Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 71. Europe Immunosuppressant Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 72. Europe Immunosuppressant Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 73. Europe Immunosuppressant Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 74. Europe Immunosuppressant Drugs Sales by Country (2018-2023) & (K MT)

Table 75. Europe Immunosuppressant Drugs Sales by Country (2024-2029) & (K MT)

Table 76. China Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 77. China Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 78. China Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 79. China Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 80. China Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 81. China Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 82. China Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 83. China Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 84. Asia Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 85. Asia Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 86. Asia Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 87. Asia Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 88. Asia Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 89. Asia Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 90. Asia Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 91. Asia Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 92. Asia Immunosuppressant Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 93. Asia Immunosuppressant Drugs Revenue by Region (2018-2023) & (US$ Million)

Table 94. Asia Immunosuppressant Drugs Revenue by Region (2024-2029) & (US$ Million)

Table 95. Asia Immunosuppressant Drugs Sales by Region (2018-2023) & (K MT)

Table 96. Asia Immunosuppressant Drugs Sales by Region (2024-2029) & (K MT)

Table 97. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Type (2018-2023) & (K MT)

Table 98. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Type (2024-2029) & (K MT)

Table 99. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 100. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 101. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Application (2018-2023) & (K MT)

Table 102. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Application (2024-2029) & (K MT)

Table 103. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 104. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 105. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 106. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Country (2018-2023) & (US$ Million)

Table 107. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue by Country (2024-2029) & (US$ Million)

Table 108. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Country (2018-2023) & (K MT)

Table 109. Middle East, Africa and Latin America Immunosuppressant Drugs Sales by Country (2024-2029) & (K MT)

Table 110. Novartis Company Information

Table 111. Novartis Description and Major Businesses

Table 112. Novartis Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 113. Novartis Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Novartis Recent Developments

Table 115. Astellas Pharma Company Information

Table 116. Astellas Pharma Description and Major Businesses

Table 117. Astellas Pharma Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 118. Astellas Pharma Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Astellas Pharma Recent Developments

Table 120. Roche Company Information

Table 121. Roche Description and Major Businesses

Table 122. Roche Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 123. Roche Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Roche Recent Developments

Table 125. Pfizer Company Information

Table 126. Pfizer Description and Major Businesses

Table 127. Pfizer Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 128. Pfizer Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Pfizer Recent Developments

Table 130. Sanofi Company Information

Table 131. Sanofi Description and Major Businesses

Table 132. Sanofi Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 133. Sanofi Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Sanofi Recent Developments

Table 135. Allergan Company Information

Table 136. Allergan Description and Major Businesses

Table 137. Allergan Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 138. Allergan Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Allergan Recent Developments

Table 140. Bristol-Myers Squibb Company Information

Table 141. Bristol-Myers Squibb Description and Major Businesses

Table 142. Bristol-Myers Squibb Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 143. Bristol-Myers Squibb Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Bristol-Myers Squibb Recent Developments

Table 145. AbbVie Company Information

Table 146. AbbVie Description and Major Businesses

Table 147. AbbVie Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 148. AbbVie Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. AbbVie Recent Developments

Table 150. Veloxis Pharmaceuticals Company Information

Table 151. Veloxis Pharmaceuticals Description and Major Businesses

Table 152. Veloxis Pharmaceuticals Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 153. Veloxis Pharmaceuticals Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Veloxis Pharmaceuticals Recent Developments

Table 155. GSK Company Information

Table 156. GSK Description and Major Businesses

Table 157. GSK Immunosuppressant Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)

Table 158. GSK Immunosuppressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. GSK Recent Developments

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Immunosuppressant Drugs Distributors List

Table 163. Immunosuppressant Drugs Customers List

Table 164. Immunosuppressant Drugs Market Trends

Table 165. Immunosuppressant Drugs Market Drivers

Table 166. Immunosuppressant Drugs Market Challenges

Table 167. Immunosuppressant Drugs Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Immunosuppressant Drugs Product Picture

Figure 2. Global Immunosuppressant Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Immunosuppressant Drugs Market Share by Type in 2022 & 2029

Figure 4. Calcineurin Inhibitors Product Picture

Figure 5. MTOR Inhibitors Product Picture

Figure 6. Anti-proliferative Agents Product Picture

Figure 7. Steroids Product Picture

Figure 8. Antibodies Product Picture

Figure 9. Global Immunosuppressant Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 10. Global Immunosuppressant Drugs Market Share by Application in 2022 & 2029

Figure 11. Kidney

Figure 12. Bone Marrow

Figure 13. Others

Figure 14. Immunosuppressant Drugs Report Years Considered

Figure 15. Global Immunosuppressant Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 16. Global Immunosuppressant Drugs Revenue 2018-2029 (US$ Million)

Figure 17. Global Immunosuppressant Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 18. Global Immunosuppressant Drugs Revenue Market Share by Region (2018-2029)

Figure 19. Global Immunosuppressant Drugs Sales 2018-2029 ((K MT)

Figure 20. Global Immunosuppressant Drugs Sales Market Share by Region (2018-2029)

Figure 21. US & Canada Immunosuppressant Drugs Sales YoY (2018-2029) & (K MT)

Figure 22. US & Canada Immunosuppressant Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 23. Europe Immunosuppressant Drugs Sales YoY (2018-2029) & (K MT)

Figure 24. Europe Immunosuppressant Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 25. China Immunosuppressant Drugs Sales YoY (2018-2029) & (K MT)

Figure 26. China Immunosuppressant Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 27. Asia (excluding China) Immunosuppressant Drugs Sales YoY (2018-2029) & (K MT)

Figure 28. Asia (excluding China) Immunosuppressant Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Immunosuppressant Drugs Sales YoY (2018-2029) & (K MT)

Figure 30. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue YoY (2018-2029) & (US$ Million)

Figure 31. The Immunosuppressant Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 32. The Top 5 and 10 Largest Manufacturers of Immunosuppressant Drugs in the World: Market Share by Immunosuppressant Drugs Revenue in 2022

Figure 33. Global Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 34. Global Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 35. Global Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 36. Global Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 37. Global Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 38. US & Canada Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 39. US & Canada Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 40. US & Canada Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 41. US & Canada Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 42. US & Canada Immunosuppressant Drugs Revenue Share by Country (2018-2029)

Figure 43. US & Canada Immunosuppressant Drugs Sales Share by Country (2018-2029)

Figure 44. U.S. Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 45. Canada Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 46. Europe Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 47. Europe Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 48. Europe Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 49. Europe Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 50. Europe Immunosuppressant Drugs Revenue Share by Country (2018-2029)

Figure 51. Europe Immunosuppressant Drugs Sales Share by Country (2018-2029)

Figure 52. Germany Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 53. France Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 54. U.K. Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 55. Italy Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 56. Russia Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 57. China Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 58. China Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 59. China Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 60. China Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 61. Asia Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 62. Asia Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 63. Asia Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 64. Asia Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 65. Asia Immunosuppressant Drugs Revenue Share by Region (2018-2029)

Figure 66. Asia Immunosuppressant Drugs Sales Share by Region (2018-2029)

Figure 67. Japan Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 68. South Korea Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 69. China Taiwan Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 70. Southeast Asia Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 71. India Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Immunosuppressant Drugs Sales Market Share by Type (2018-2029)

Figure 73. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue Market Share by Type (2018-2029)

Figure 74. Middle East, Africa and Latin America Immunosuppressant Drugs Sales Market Share by Application (2018-2029)

Figure 75. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue Market Share by Application (2018-2029)

Figure 76. Middle East, Africa and Latin America Immunosuppressant Drugs Revenue Share by Country (2018-2029)

Figure 77. Middle East, Africa and Latin America Immunosuppressant Drugs Sales Share by Country (2018-2029)

Figure 78. Brazil Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 79. Mexico Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 80. Turkey Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 81. Israel Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 82. GCC Countries Immunosuppressant Drugs Revenue (2018-2029) & (US$ Million)

Figure 83. Immunosuppressant Drugs Value Chain

Figure 84. Immunosuppressant Drugs Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Immunosuppressant Drugs Market Insights, Forecast to 2029

Published Date: June 2023

Report Code: QYRE-Auto-13N6980

Global Immunosuppressant Drugs Market Insights, Forecast to 2029

FEATURED COMPANIES

Immunosuppressant Drugs Market Size

Immunosuppressant Drugs Market

Report Includes:

Scope of Immunosuppressant Drugs Market Report

Chapter Outline

FEATURED COMPANIES

RELATED REPORTS